In parallel with the 2024 JP Morgan Healthcare Conference, PCI is honored to welcome a stellar group of innovators to our Innovation @ Penn program in San Francisco on January 8, 2024.

This year’s panel features an exciting line-up of experts in the field of brain science and neurobiology, including leading luminaries Brian Litt, MD, Perelman Professor of Neurology at Penn Medicine and Director, Penn Health-Tech, Michael Kahana, PhD, Penn SAS Professor of Psychology at the University of Pennsylvania and Co-Founder & Chairman of the Scientific Advisory Board for Nia Therapeutics, and Anna Wexler, PhD, Assistant Professor of Medical Ethics and Health Policy at the University of Pennsylvania.

Each year, the Innovation @ Penn program fosters in-depth discussions about the most cutting-edge developments in technology and innovation, and attracts professionals from across the global pharma, medtech and biotech industries. This event is a great opportunity to learn about emerging innovation and explore new areas for research, investment and partnership with Penn.

After the panel concludes, a networking reception will follow.

Register here: https://www.eventbrite.com/e/innovation-penn-the-future-of-neuroscience-innovation-tickets-748583943727?aff=oddtdtcreator